AREXVY CPT Vaccine Code: 90679

Vaccine & Product Overview

HCPCS Descriptor Respiratory syncytial virus vaccine, preF, recombinant, subunit, adjuvanted, for intramuscular use

Manufacturer Glaxo Smithkline Pharmaceuticals

Route of Administration Intramuscular

Generic Status Single-Source; Branded

Dosage Form Kit

About AREXVY

Arexvy is a medication aligned to the HCPCS CPT Drug Code: 90679 for billing, pricing, and reimbursement purposes in the United States. Classified under Vaccine, it is administered via the intramuscular route and manufactured by Glaxo Smithkline Pharmaceuticals.

Manufacturers, reach out to us to add more information.

NDC Code Information

1 NDC package is crosswalked to 90679. Package detail is available to logged-in subscribers.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
•••••-••••-•• Log in to view	AREXVY

Login to view 1 NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

AREXVY Pricing & Reimbursement

90679 Private Payer Reimbursement

$341.68 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

AREXVY Vaccine Administration Codes

CPT Code	Description
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), one vaccine (single or combination vaccine/toxoid)
90472	Immunization administration (each additional vaccine or toxoid), when performed in conjunction with primary procedure.

AREXVY Medically Unlikely Edits (MUE)

The most billing units of 90679 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 dose.

Practitioner Office & Hospital Outpatient

1 unit / day

Same limit in both settings

MAI 2 · Date of Service Edit: Policy. Absolute per-day limit set by policy or regulation; units above it are not payable, and denials are not appealable on medical-necessity grounds. See all MUE limits →

AREXVY Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Respiratory syncytial virus (RSV) lower respiratory tract disease (prevention)

Frequently Asked Questions

Is there a manufacturer-published billing and coding guide for Arexvy?

Billing and coding information for AREXVY can be found through GLAXO SMITH KLINE. Visit Here →

Are there any available patient assistance programs for Arexvy?

AREXVY patient assistance information can be found through GLAXO SMITH KLINE. Visit Here →

Where can I find Arexvy prescribing information?

Arexvy prescribing information can be found at the link below. Visit Here →

Is there available side effect information for Arexvy?

Side effect information for Arexvy can be found through Medline Plus at the link below. Visit Here →

Does billing AREXVY require JZ/JW wastage modifiers?

CMS does not include AREXVY (90679) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing 90679. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.